2019
DOI: 10.1074/jbc.ra119.009438
|View full text |Cite
|
Sign up to set email alerts
|

Fidelity of prespacer capture and processing is governed by the PAM-mediated interactions of Cas1-2 adaptation complex in CRISPR-Cas type I-E system

Abstract: Edited by Joel M. Gottesfeld Prokaryotes deploy CRISPR-Cas-based RNA-guided adaptive immunity to fend off mobile genetic elements such as phages and plasmids. During CRISPR adaptation, which is the first stage of CRISPR immunity, the Cas1-2 integrase complex captures invader-derived prespacer DNA and specifically integrates it at the leader-repeat junction as spacers. For this integration, several variants of CRISPR-Cas systems use Cas4 as an indispensable nuclease for selectively processing the protospacer ad… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 93 publications
0
5
0
Order By: Relevance
“…While certain type I-E CRISPR systems achieve adaptive immunity through the in vitro exonuclease activity displayed by Cas4 proteins, [14] many CRISPR-Cas systems lack Cas4 yet possess the ability to specifically and accurately select and process PAMs. [15] The mechanisms and structures guiding these systems in PAM Firstly, it involves ruler-guided modification and simultaneous PAM protection to modify exogenous DNA. Subsequently, the trimmed exogenous DNA becomes fully integrated into the host genome through two nucleophilic attacks.…”
Section: Deddh Plays An Auxiliary Role In Replacing Cas4 In Some Cris...mentioning
confidence: 99%
See 1 more Smart Citation
“…While certain type I-E CRISPR systems achieve adaptive immunity through the in vitro exonuclease activity displayed by Cas4 proteins, [14] many CRISPR-Cas systems lack Cas4 yet possess the ability to specifically and accurately select and process PAMs. [15] The mechanisms and structures guiding these systems in PAM Firstly, it involves ruler-guided modification and simultaneous PAM protection to modify exogenous DNA. Subsequently, the trimmed exogenous DNA becomes fully integrated into the host genome through two nucleophilic attacks.…”
Section: Deddh Plays An Auxiliary Role In Replacing Cas4 In Some Cris...mentioning
confidence: 99%
“…While certain type I‐E CRISPR systems achieve adaptive immunity through the in vitro exonuclease activity displayed by Cas4 proteins, [ 14 ] many CRISPR‐Cas systems lack Cas4 yet possess the ability to specifically and accurately select and process PAMs. [ 15 ] The mechanisms and structures guiding these systems in PAM sequence selection and processing have remained elusive. A recent study has unveiled a breakthrough, indicating that the type I‐E CRISPR system accomplishes PAM selection and processing through the close collaboration between DEDDh and Cas1‐Cas2 complexes ( Figure 2 ).…”
Section: Deddh Plays An Auxiliary Role In Replacing Cas4 In Some Cris...mentioning
confidence: 99%
“…As such, Cas4 prevents the integration of nonfunctional spacers with an inappropriate length or PAM (Kieper et al 2018;Lee et al 2018Lee et al , 2019Rollie et al 2018;Shiimori et al 2018;Almendros et al 2019). The function of Cas4 and DnaQ can also be performed by non-CRISPR nucleases in other systems (Yoganand et al 2019).…”
Section: Adaptationmentioning
confidence: 99%
“…In the case of the I-E system of E. coli (devoid of Cas4 and with a Cas2 protein that does not exhibit exonuclease activity), DnaQ and ExoT exonucleases, as well as the proofreading subunit of the DNA polymerase III, have been suggested to be involved in the prespacer trimming (Kim et al 2020 ; Ramachandran et al 2020 ). According to the model proposed, once the prespacer is loaded into the Cas1-Cas2 complex and the PAM is recognised, host nucleases will degrade the ends of the prespacer until reaching the region protected by the complex (Yoganand et al 2019 ).…”
Section: The General Crispr-cas Mechanismmentioning
confidence: 99%